AEGERION PHARMACEUTICALS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.97 USD | +5.35% |
|
+4.23% | -80.50% |
| 2015 | AbbVie : Venture capitalists ride biotech wave one drug at a time | RE |
| 2015 | Aegerion Pharmaceuticals : Exclusive: Top investors push Aegerion to oust CEO, consider sale - sources | RE |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Sheila Frame
PSD | President | 62 | - |
Elizabeth Jobes
BRD | Director/Board Member | 57 | - |
Ailish Hogan
SEC | Corporate Secretary | - | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sheila Frame
PSD | President | 62 | - |
Elizabeth Jobes
BRD | Director/Board Member | 57 | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 30,796,088 | 28,908,592 ( 93.87 %) | 1,251,000 ( 4.062 %) | 93.87 % |
Company contact information
Aegerion Pharmaceuticals, Inc.
160 Federal Street 21st Floor
02110, Boston
+617-500-7867
http://www.aegerion.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- AEGR Stock
- Company Aegerion Pharmaceuticals, Inc.
